Adaptos®Fuse Bone Graft

FDA 510(k) K253524 · Biomendex OY

Substantially Equivalent

510(k) numberK253524

Submission

Device name
Adaptos®Fuse Bone Graft
Applicant
Biomendex OY
Tampere, FI
Received
November 13, 2025
Decision date
February 17, 2026
Decision
Substantially Equivalent (SESE)
Type
Traditional 510(k)
Summary
510(k) summary available from FDA

Official FDA 510(k) record

Device classification

Product code
MQV – Filler, Bone Void, Calcium Compound
Device class
Class II (moderate risk)
Regulation
21 CFR 888.3045
Specialty
Orthopedic
Implant
Yes

Other 510(k)s with product code MQV

510(k)DeviceApplicantDecision
K262230Mg OSTEOREVIVE™;Mg OSTEOCRETE™MQV · Traditional Bone Solutions, Inc.09/11/2026SE
K260364Device 300419 StripMQV · Traditional Geistlich Pharma AG06/02/2026SE
K252797JAZBI™ Resorbable Bone Void FillerMQV · Traditional Sdip Innovations Pty, Ltd.05/26/2026SE
K261008Vitoss® BiModal Bioactive Bone Graft Substitute Foam Strip; Vitoss® BiModal Bioactive…MQV · Special Stryker Spine04/24/2026SE
K253147FIBERGRAFT™ BG Putty GPS Bone Graft Substitute FIBERGRAFT™ BG Putty Bone Graft…MQV · Special Prosidyan, Inc.10/22/2025SE
K251522Mg OSTEOINJECT™; Mg OSTEOREVIVE™; Mg OSTEOCRETE™MQV · Traditional Bone Solutions, Inc.10/13/2025SE
K252085Allomatrix (Allomatrix Injectable Putty; Allomatrix C; Allomatrix DR; Allomatrix Custom)MQV · Traditional Wright Medical Technology, Inc. (Stryker…09/30/2025SE
K251556Device 300423 GranulesMQV · Traditional Geistlich Pharma AG07/17/2025SE
K251720OsteoFlo HydroFiberMQV · Special SurGenTec, LLC07/02/2025SE
K251193Grafton™ DBM; Grafton Plus™ DBM Paste; Magnifuse™ Bone GraftMQV · Traditional Medtronic Sofamor Danek, Inc.06/12/2025SE

Questions and answers

When was Adaptos®Fuse Bone Graft cleared by the FDA?

Adaptos®Fuse Bone Graft (K253524) received a 510(k) decision of Substantially Equivalent on February 17, 2026, 96 days after the submission was received.

What is the product code of K253524?

The FDA product code is MQV – Filler, Bone Void, Calcium Compound, a Class II (moderate risk) device regulated under 21 CFR 888.3045.